Similar articles

• Perspective: Biotech funding trends: Insights from entrepreneurs and investors.

  Gruber AC. Gruber AC. Biotechnol J. 2009 Aug;4(8):1102-5. doi: 10.1002/biot.200900147. Biotechnol J. 2009. PMID: 19685460
• Concern mounts over Munich's BioRegio money.

  Fürst I. Fürst I. Nat Biotechnol. 1998 Jul;16(7):614-5. doi: 10.1038/nbt0798-614. Nat Biotechnol. 1998. PMID: 9661185 No abstract available.
• Success in an uneven market.

  Russo E. Russo E. Nature. 2003 Jul 31;424(6948):597. doi: 10.1038/nj6948-597a. Nature. 2003. PMID: 12891372 No abstract available.
• Can biotech deliver new antibiotics?

  Barrett JF. Barrett JF. Curr Opin Microbiol. 2005 Oct;8(5):498-503. doi: 10.1016/j.mib.2005.08.007. Curr Opin Microbiol. 2005. PMID: 16125445 Review.
• Foundation Review: Transgenic animals and their impact on the drug discovery industry.

  Dunn DA, Pinkert CA, Kooyman DL. Dunn DA, et al. Drug Discov Today. 2005 Jun 1;10(11):757-67. doi: 10.1016/S1359-6446(05)03452-5. Drug Discov Today. 2005. PMID: 15922934 Review.